The DOI matches its Crossref record.
Bimatoprost Ophthalmic Solution 0.03% for Eyebrow Growth
Abstract
Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts Enter your Email address: Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. Subscribe to eTOC Secondary Logo Journal Logo All Articles Images Videos Podcasts Blogs Advanced Search Toggle navigation Subscribe Register Login Articles & Issues Current IssuePrevious IssuesPublished Ahead-of-PrintSpecial Issues Collections Advancement FlapCartilage GraphCompsite GraphEar ReconstructionEyelid ReconstructionFull Thickness Skin GraphInterpolation FlapLip ReconstructionNasal ALANasal ReconstructionNasal Tip - SidewallPull Through FlapRotation FlapSkin Cancer AwarenessSoft TriangleTransposistion Flap VideosPodcastFor Authors Submit a ManuscriptInformation for AuthorsLanguage Editing ServicesAuthor Permissions Journal Info About the JournalEditorial BoardAbout the societyAdvertisingSubscription ServicesReprintsOpen AccessRights and PermissionsNZSCM Member Info All Articles Images Videos Podcasts Blogs Advanced Search
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Bimatoprost 0.03% and 0.01% formulations have been shown in recent studies to be safe and efficacious as a therapeutic potential for eyebrow hypotrichosis.
“Bimatoprost in its 0.03 and 0.01 formulations was studied in a number of recent studies and compared to one another which revealed its safety and efficacy as a therapeutic potential for eyebrow hypotrichosis [7–10].”
Earlier case reports demonstrated good response to eyebrow thinning with the use of bimatoprost 0.03% for 16 weeks and with no side effects reported.
“Earlier case reports demonstrated good response to eyebrow thinning with the use of bimatoprost 0.03% for 16 weeks and with no side effects reported [8, 9].”
Citations
Cited by
Sorted by citations
Lee, S., Tanglertsampan, C., Tanchotikul, M., & Worapunpong, N. (2014) · The Journal of Dermatology · doi:10.1111/1346-8138.12275 · Cited by 19
Zaky, M. S., Hashem, O. A., Mahfouz, S. M., & Elsaie, M. L. (2023) · Archives of Dermatological Research · doi:10.1007/s00403-023-02679-2 · Cited by 6
Metadata
- Authors
- ELIAS, M. J., WEISS, J., & WEISS, E.
- Affiliations
- Nova Southeastern University (US)
- University of Miami (US)
- ORCID
- WEISS, JONATHAN
- Venue
- Dermatologic Surgery
- Published
- 2011-06-28
- Volume
- 37
- Issue
- 7
- Pages
- 1057-1059
- ISSN
- 1076-0512 (ISSN-L)
- OpenAlex
- W2160573932
- Cited by
- 21
- References
- 0
- Citations by year
- 2025: 1 · 2023: 2 · 2022: 3 · 2019: 3 · 2018: 2 · 2017: 1 · 2015: 1 · 2014: 1 · 2013: 4 · 2012: 3
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Dermatologic Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Hair Growth and Disorders
- Health Sciences › Medicine › Dermatology › Facial Rejuvenation and Surgery Techniques
- Health Sciences › Medicine › Surgery › Reconstructive Facial Surgery Techniques
- Keywords
- bimatoprost, eye drops, eyelash growth, prostamide, hair growth promotion
- MeSH terms
- Bimatoprost, Administration, Topical, Amides, Antihypertensive Agents, Cloprostenol, Eyebrows, Female, Humans, Male, Middle Aged, Off-Label Use
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
